Kent, United Kingdom

Edward Davison



Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 124(Granted Patents)


Location History:

  • Margate, GB (1989)
  • Kent, GB (1999)

Company Filing History:


Years Active: 1989-1999

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Edward Davison

Introduction

Edward Davison is a notable inventor based in Kent, GB, recognized for his contributions to pharmaceutical formulations. With a total of two patents to his name, Davison has made significant strides in the field of antiparasitic and pharmaceutical salt formulations.

Latest Patents

One of Davison's latest patents is focused on antiparasitic formulations. This parenteral formulation for 25-cyclohexyl-avermectin Bl, compound (I), is effective against both internal and external parasites. It is well tolerated by animals when administered subcutaneously and intramuscularly, and it is compatible with conventional injection equipment. The solution comprises compound (I) in a solvent consisting of 50 to 95% by volume of sesame oil, with the remainder being ethyl oleate. Another significant patent involves improved pharmaceutical salts of amlodipine, particularly the besylate salt, along with pharmaceutical compositions thereof. These salts are useful as anti-ischaemic and anti-hypertensive agents.

Career Highlights

Davison is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work focuses on developing innovative solutions that address critical health issues.

Collaborations

Throughout his career, Davison has collaborated with esteemed colleagues, including James I Wells and Stephen Richard Wicks. Their combined expertise has contributed to the advancement of pharmaceutical innovations.

Conclusion

Edward Davison's work in the field of pharmaceuticals showcases his commitment to innovation and improving health outcomes. His patents reflect a deep understanding of the complexities involved in drug formulation and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…